DE3686438D1 - Tumorverbundenes antigen. - Google Patents

Tumorverbundenes antigen.

Info

Publication number
DE3686438D1
DE3686438D1 DE8686303042T DE3686438T DE3686438D1 DE 3686438 D1 DE3686438 D1 DE 3686438D1 DE 8686303042 T DE8686303042 T DE 8686303042T DE 3686438 T DE3686438 T DE 3686438T DE 3686438 D1 DE3686438 D1 DE 3686438D1
Authority
DE
Germany
Prior art keywords
antigen
tumor
antig
cck061
glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686303042T
Other languages
English (en)
Other versions
DE3686438T2 (de
Inventor
Lana Grauer
Julia Leung
Joy Koda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of DE3686438D1 publication Critical patent/DE3686438D1/de
Application granted granted Critical
Publication of DE3686438T2 publication Critical patent/DE3686438T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1063—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from stomach or intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8686303042T 1985-04-22 1986-04-22 Tumorverbundenes antigen. Expired - Fee Related DE3686438T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72620285A 1985-04-22 1985-04-22

Publications (2)

Publication Number Publication Date
DE3686438D1 true DE3686438D1 (de) 1992-09-24
DE3686438T2 DE3686438T2 (de) 1993-01-21

Family

ID=24917624

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686303042T Expired - Fee Related DE3686438T2 (de) 1985-04-22 1986-04-22 Tumorverbundenes antigen.

Country Status (9)

Country Link
EP (1) EP0200464B1 (de)
JP (1) JPS61289897A (de)
AT (1) ATE79632T1 (de)
AU (2) AU599589B2 (de)
DE (1) DE3686438T2 (de)
DK (1) DK185086A (de)
ES (2) ES8800604A1 (de)
FI (1) FI87141C (de)
NO (1) NO170810C (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU613590B2 (en) * 1986-11-19 1991-08-08 Bristol-Myers Squibb Company Hybridomas producing monoclonal antibodies to new mucin epitopes
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
JPS63157995A (ja) * 1986-12-18 1988-06-30 Kyowa Hakko Kogyo Co Ltd 抗ヒト大腸癌単クロ−ン性抗体ａｃｃ−５７４
DK169987D0 (da) * 1987-04-03 1987-04-03 Jens Christian Jensenius Human tumor-associated antigen, ca-ou1
JP2688824B2 (ja) * 1987-05-29 1997-12-10 郁男 山科 単クローン抗体ｎｋｙ１３
US5073493A (en) * 1987-05-29 1991-12-17 Ikuo Yamashina Monoclonal antibody nky13
ATE137674T1 (de) * 1987-07-02 1996-05-15 Akzo Nobel Nv Von mca 16-88 erkanntes antigen
EP0397419A3 (de) * 1989-05-10 1991-04-03 Hybritech Incorporated Tumorassoziiertes Antigen, Antikörper sowie Zusammensetzungen und Verwendung hierfür
DE69029270T2 (de) * 1989-09-15 1997-03-27 Genetic Systems Corp HYBRIDOMA CT43, DAS EIN ANTIKöRPER GEGEN EIN MUCINEPITOP VON DARMKREBS ERZEUGT
US20010055596A1 (en) * 2000-03-24 2001-12-27 Meagher Madeleine Joy Compositions and methods for therapy and diagnosis of colon cancer
ES2468394T3 (es) * 2008-12-18 2014-06-16 Eidia Co., Ltd. Método para el diagnóstico de la fibrosis qu�stica mediante el uso de los niveles de KL-6

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
NZ212419A (en) * 1984-06-25 1988-08-30 Mucan Diagnostics Pty Ltd In vitro diagnostic test for detecting cancer cells producing mucin antigens
DK172686A (da) * 1985-04-22 1986-10-23 Hybritech Inc Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet

Also Published As

Publication number Publication date
ATE79632T1 (de) 1992-09-15
NO170810C (no) 1992-12-09
FI861692A0 (fi) 1986-04-22
FI861692A (fi) 1986-10-23
EP0200464A3 (en) 1988-05-04
AU627084B2 (en) 1992-08-13
DK185086A (da) 1986-10-23
ES557680A0 (es) 1989-05-16
ES8800604A1 (es) 1987-11-16
ES554209A0 (es) 1987-11-16
ES8900247A1 (es) 1989-05-16
EP0200464B1 (de) 1992-08-19
DK185086D0 (da) 1986-04-22
JPS61289897A (ja) 1986-12-19
NO861577L (no) 1986-10-23
FI87141C (fi) 1992-12-10
DE3686438T2 (de) 1993-01-21
AU6556990A (en) 1991-01-17
EP0200464A2 (de) 1986-11-05
AU5646986A (en) 1987-10-29
NO170810B (no) 1992-08-31
AU599589B2 (en) 1990-07-26
FI87141B (fi) 1992-08-31

Similar Documents

Publication Publication Date Title
ATE117370T1 (de) Chimärer antikörper mit spezifität für menschliches tumor-antigen.
ATE56046T1 (de) Monoklonale antikoerper gegen humane brustkarzinomzellen und ihre verwendung in der diagnose und therapie.
DE3686438D1 (de) Tumorverbundenes antigen.
ATE132629T1 (de) Harnwegstumor-assoziiertes antigen, verwendung von antigenen untereinheiten und nachweisverfahren
ES8800603A1 (es) Un metodo para producir anticuerpos monoclonales
EP0380607A4 (en) Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
DE69633976D1 (de) Monoklonale antikörper und antigene mit bezug zum menschlichen lungenadenokarzinom und immunoassay-verfahren unter verwendung desselben
ATE86261T1 (de) Tumorassoziiertes antigen.
ATE92081T1 (de) Tumorassoziiertes antigen.
EP0397419A3 (de) Tumorassoziiertes Antigen, Antikörper sowie Zusammensetzungen und Verwendung hierfür
ATE182178T1 (de) Monoklonaler antikörper, polypeptide und deren herstellung
EP0332421A3 (en) Monoclonal antibodies recognizing human psti, hybridomas producing the same, and their preparation and use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee